Skip to main content
NASDAQ:VKTX

Viking Therapeutics News Headlines

$5.92
-0.11 (-1.82 %)
(As of 05/12/2021 12:00 AM ET)
Add
Compare
Today's Range
$5.90
$6.24
50-Day Range
$5.71
$6.39
52-Week Range
$5.26
$10.09
Volume738,332 shs
Average Volume1.27 million shs
Market Capitalization$462.35 million
P/E RatioN/A
Dividend YieldN/A
Beta2.02

Headlines

Viking Therapeutics (NASDAQ VKTX) News Headlines Today

SourceHeadline
All Analysts Agree that these 3 Stocks are a BuyAll Analysts Agree that these 3 Stocks are a Buy
marketbeat.com - February 4 at 1:11 PM
 Brokerages Expect Viking Therapeutics, Inc. (NASDAQ:VKTX) to Announce -$0.19 EPS Brokerages Expect Viking Therapeutics, Inc. (NASDAQ:VKTX) to Announce -$0.19 EPS
americanbankingnews.com - May 8 at 9:12 PM
B. Riley Analysts Reduce Earnings Estimates for Viking Therapeutics, Inc. (NASDAQ:VKTX)B. Riley Analysts Reduce Earnings Estimates for Viking Therapeutics, Inc. (NASDAQ:VKTX)
americanbankingnews.com - May 6 at 7:46 AM
Viking Therapeutics, Inc. (NASDAQ:VKTX) Given Average Rating of "Buy" by BrokeragesViking Therapeutics, Inc. (NASDAQ:VKTX) Given Average Rating of "Buy" by Brokerages
americanbankingnews.com - May 5 at 4:46 AM
Viking Therapeutics (NASDAQ:VKTX) Receives Buy Rating from SVB LeerinkViking Therapeutics (NASDAQ:VKTX) Receives Buy Rating from SVB Leerink
americanbankingnews.com - May 3 at 6:28 AM
William Blair Comments on Viking Therapeutics, Inc.s FY2021 Earnings (NASDAQ:VKTX)William Blair Comments on Viking Therapeutics, Inc.'s FY2021 Earnings (NASDAQ:VKTX)
americanbankingnews.com - May 3 at 3:22 AM
Viking Therapeutics, Inc. Forecasted to Post Q2 2021 Earnings of ($0.21) Per Share (NASDAQ:VKTX)Viking Therapeutics, Inc. Forecasted to Post Q2 2021 Earnings of ($0.21) Per Share (NASDAQ:VKTX)
americanbankingnews.com - May 3 at 1:32 AM
Viking Therapeutics, Inc. to Post Q2 2021 Earnings of ($0.19) Per Share, Truist Securiti Forecasts (NASDAQ:VKTX)Viking Therapeutics, Inc. to Post Q2 2021 Earnings of ($0.19) Per Share, Truist Securiti Forecasts (NASDAQ:VKTX)
americanbankingnews.com - May 3 at 1:32 AM
Viking Therapeutics (NASDAQ:VKTX) Releases Quarterly  Earnings ResultsViking Therapeutics (NASDAQ:VKTX) Releases Quarterly Earnings Results
americanbankingnews.com - April 29 at 2:34 PM
Viking Therapeutics (VKTX) Q1 2021 Earnings Call TranscriptViking Therapeutics (VKTX) Q1 2021 Earnings Call Transcript
finance.yahoo.com - April 29 at 1:15 AM
Viking Therapeutics (VKTX) to Release Earnings on WednesdayViking Therapeutics (VKTX) to Release Earnings on Wednesday
americanbankingnews.com - April 22 at 10:16 AM
Viking Therapeutics to Report Financial Results for First Quarter 2021 on April 28, 2021Viking Therapeutics to Report Financial Results for First Quarter 2021 on April 28, 2021
finance.yahoo.com - April 21 at 7:31 PM
-$0.18 EPS Expected for Viking Therapeutics, Inc. (NASDAQ:VKTX) This Quarter-$0.18 EPS Expected for Viking Therapeutics, Inc. (NASDAQ:VKTX) This Quarter
americanbankingnews.com - April 21 at 10:22 AM
Contrasting Mustang Bio (NASDAQ:MBIO) & Viking Therapeutics (NASDAQ:VKTX)Contrasting Mustang Bio (NASDAQ:MBIO) & Viking Therapeutics (NASDAQ:VKTX)
americanbankingnews.com - April 19 at 5:04 PM
Bumbershoot Holdings: “Viking Therapeutics (VKTX) Struggled Right Off the Bat”Bumbershoot Holdings: “Viking Therapeutics (VKTX) Struggled Right Off the Bat”
finance.yahoo.com - April 8 at 2:03 PM
Viking Therapeutics to Present at 20th Annual Needham Virtual Healthcare ConferenceViking Therapeutics to Present at 20th Annual Needham Virtual Healthcare Conference
finance.yahoo.com - April 7 at 6:44 PM
Viking Therapeutics to Participate at Upcoming Investor ConferencesViking Therapeutics to Participate at Upcoming Investor Conferences
finance.yahoo.com - March 4 at 6:57 PM
Viking Therapeutics (VKTX) Q4 2020 Earnings Call TranscriptViking Therapeutics (VKTX) Q4 2020 Earnings Call Transcript
finance.yahoo.com - February 25 at 8:45 AM
Vectoring In On Viking TherapeuticsVectoring In On Viking Therapeutics
seekingalpha.com - February 21 at 10:57 PM
Viking Therapeutics, Inc. 2020 Q4 - Results - Earnings Call PresentationViking Therapeutics, Inc. 2020 Q4 - Results - Earnings Call Presentation
seekingalpha.com - February 19 at 8:24 AM
Viking Therapeutics (VKTX) CEO Brian Lian on Q4 2020 Results - Earnings Call TranscriptViking Therapeutics' (VKTX) CEO Brian Lian on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - February 18 at 11:18 PM
Viking Therapeutics Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate UpdateViking Therapeutics Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - February 17 at 5:52 PM
Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2020 on February 17, 2021Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2020 on February 17, 2021
finance.yahoo.com - February 10 at 5:43 PM
Notable Friday Option Activity: TDC, SPOT, VKTXNotable Friday Option Activity: TDC, SPOT, VKTX
nasdaq.com - February 6 at 1:22 AM
What Type Of Shareholders Make Up Viking Therapeutics, Inc.s (NASDAQ:VKTX) Share Registry?What Type Of Shareholders Make Up Viking Therapeutics, Inc.'s (NASDAQ:VKTX) Share Registry?
finance.yahoo.com - January 26 at 2:00 PM
VKTX: Multiple Milestones Upcoming in 2021…VKTX: Multiple Milestones Upcoming in 2021…
finance.yahoo.com - January 13 at 11:21 AM
Viking Therapeutics Announces Senior Management Team AppointmentsViking Therapeutics Announces Senior Management Team Appointments
finance.yahoo.com - January 6 at 5:58 PM
Viking Therapeutics to Present at H.C. Wainwright BioConnect 2021 ConferenceViking Therapeutics to Present at H.C. Wainwright BioConnect 2021 Conference
finance.yahoo.com - January 5 at 8:12 PM
Is VKTX A Good Stock To Buy Now?Is VKTX A Good Stock To Buy Now?
finance.yahoo.com - December 15 at 5:34 PM
Viking Therapeutics: Progressing Steadily, But Concerns RemainViking Therapeutics: Progressing Steadily, But Concerns Remain
seekingalpha.com - November 29 at 8:21 AM
3 Stocks with Jaw-Dropping Growth Potential3 Stocks with Jaw-Dropping Growth Potential
finance.yahoo.com - November 23 at 10:16 AM
Viking Therapeutics to Present at Stifel Healthcare Conference 2020Viking Therapeutics to Present at Stifel Healthcare Conference 2020
finance.yahoo.com - November 10 at 5:26 PM
Viking Therapeutics Inc Strong BuyViking Therapeutics Inc Strong Buy
markets.businessinsider.com - November 2 at 7:08 PM
VKTX: Phase 1 Trial of VK0214 Underway…VKTX: Phase 1 Trial of VK0214 Underway…
finance.yahoo.com - October 30 at 2:05 PM
Viking Therapeutics, Inc. (VKTX) CEO Brian Lian on Q3 2020 Results - Earnings Call TranscriptViking Therapeutics, Inc. (VKTX) CEO Brian Lian on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - October 28 at 11:41 PM
Here's Why We're Not Too Worried About Viking Therapeutics' (NASDAQ:VKTX) Cash Burn SituationHere's Why We're Not Too Worried About Viking Therapeutics' (NASDAQ:VKTX) Cash Burn Situation
finance.yahoo.com - October 28 at 6:40 PM
Viking Therapeutics, Inc. to Host Earnings CallViking Therapeutics, Inc. to Host Earnings Call
finance.yahoo.com - October 28 at 6:40 PM
Viking Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate UpdateViking Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - October 28 at 6:40 PM
Viking Therapeutics to Report Financial Results for Third Quarter 2020 on October 28, 2020Viking Therapeutics to Report Financial Results for Third Quarter 2020 on October 28, 2020
finance.yahoo.com - October 21 at 5:49 PM
Viking Therapeutics IncViking Therapeutics Inc
reuters.com - October 20 at 2:56 PM
VIKING THERAPEUT.DL -,005 (1VT.MU)VIKING THERAPEUT.DL -,005 (1VT.MU)
in.finance.yahoo.com - October 12 at 9:57 PM
4 Sectors Moving Up In Wednesdays After-Market Session4 Sectors Moving Up In Wednesday's After-Market Session
msn.com - September 23 at 6:55 PM
Viking Therapeutics launches early-stage study of candidate for rare nervous system disorderViking Therapeutics launches early-stage study of candidate for rare nervous system disorder
seekingalpha.com - September 9 at 9:33 AM
Viking Therapeutics Announces Initiation of Phase 1 Clinical Trial of VK0214Viking Therapeutics Announces Initiation of Phase 1 Clinical Trial of VK0214
finance.yahoo.com - September 9 at 9:33 AM
Buy the Dip in Viking Therapeutics Stock, Says AnalystBuy the Dip in Viking Therapeutics Stock, Says Analyst
finance.yahoo.com - September 1 at 8:04 PM
VKTX: Continued Liver Fat Reductions Four Weeks Following Final Dose of VK2809 in Phase 2 Trial…VKTX: Continued Liver Fat Reductions Four Weeks Following Final Dose of VK2809 in Phase 2 Trial…
finance.yahoo.com - August 31 at 2:00 PM
Viking Therapeutics VK2809 shows durable effect in mid-stage fatty liver studyViking Therapeutics' VK2809 shows durable effect in mid-stage fatty liver study
seekingalpha.com - August 28 at 8:56 AM
Viking Therapeutics Presents New Data from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol at The Digital International Liver Congress™ 2020Viking Therapeutics Presents New Data from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol at The Digital International Liver Congress™ 2020
finance.yahoo.com - August 28 at 8:56 AM
Brokers bullish on Viking Therapeutics Inc sharesBrokers bullish on Viking Therapeutics Inc shares
uk.finance.yahoo.com - August 24 at 7:38 AM
Viking Therapeutics to Present New Data from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol at The Digital International Liver Congress™ 2020Viking Therapeutics to Present New Data from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol at The Digital International Liver Congress™ 2020
finance.yahoo.com - August 20 at 8:33 AM
VIKING THERAPEUT.DL -,005 (1VT.BE)VIKING THERAPEUT.DL -,005 (1VT.BE)
sg.finance.yahoo.com - August 16 at 9:18 AM
This page was last updated on 5/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.